Cargando…
Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the basel...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660471/ https://www.ncbi.nlm.nih.gov/pubmed/19171721 http://dx.doi.org/10.2337/dc08-1641 |
_version_ | 1782165739602444288 |
---|---|
author | Marcovecchio, M. Loredana Dalton, R. Neil Prevost, A. Toby Acerini, Carlo L. Barrett, Timothy G. Cooper, Jason D. Edge, Julie Neil, Andrew Shield, Julian Widmer, Barry Todd, John A. Dunger, David B. |
author_facet | Marcovecchio, M. Loredana Dalton, R. Neil Prevost, A. Toby Acerini, Carlo L. Barrett, Timothy G. Cooper, Jason D. Edge, Julie Neil, Andrew Shield, Julian Widmer, Barry Todd, John A. Dunger, David B. |
author_sort | Marcovecchio, M. Loredana |
collection | PubMed |
description | OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the baseline assessment was 14.5 years (range 10–21.1), and median diabetes duration was 4.8 years (0.2–17). A total of 2,194 nonfasting blood samples were collected longitudinally for determination of total cholesterol, LDL cholesterol, HDL cholesterol, TG, and non-HDL cholesterol. Additional annually collected data on anthropometric parameters, A1C, and albumin-to-creatinine ratio (ACR) were available. RESULTS: Total cholesterol, LDL cholesterol, HDL cholesterol, and non-HDL cholesterol were higher in females than in males (all P < 0.001). A significant proportion of subjects presented sustained lipid abnormalities during follow-up: total cholesterol >5.2 mmol/l (18.6%), non-HDL cholesterol >3.4 mmol/l (25.9%), TG >1.7 mmol/l (20.1%), and LDL cholesterol >3.4 mmol/l (9.6%). Age and duration were significantly related to all lipid parameters (P < 0.001); A1C was independently related to all parameters (P < 0.001) except HDL cholesterol, whereas BMI SD scores were related to all parameters (P < 0.05) except total cholesterol. Total cholesterol and non-HDL cholesterol were independently related to longitudinal changes in ACR (B coefficient ± SE): 0.03 ± 0.01/1 mmol/l, P = 0.009, and 0.32 ± 0.014/1 mmol/l, P = 0.02, respectively. Overall mean total cholesterol and non-HDL cholesterol were higher in microalbuminuria positive (n = 115) than in normoalbuminuric subjects (n = 780): total cholesterol 4.7 ± 1.2 vs. 4.5 ± 0.8 mmol/l (P = 0.04) and non-HDL cholesterol 3.2 ± 1.2 vs. 2.9 ± 0.8 mmol/l (P = 0.03). CONCLUSIONS: In this longitudinal study of adolescents with type 1 diabetes, sustained lipid abnormalities were related to age, duration, BMI, and A1C. Furthermore, ACR was related to both total cholesterol and non-HDL cholesterol, indicating a potential role in the pathogenesis of diabetic nephropathy. |
format | Text |
id | pubmed-2660471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-26604712010-04-01 Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes Marcovecchio, M. Loredana Dalton, R. Neil Prevost, A. Toby Acerini, Carlo L. Barrett, Timothy G. Cooper, Jason D. Edge, Julie Neil, Andrew Shield, Julian Widmer, Barry Todd, John A. Dunger, David B. Diabetes Care Original Research OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the baseline assessment was 14.5 years (range 10–21.1), and median diabetes duration was 4.8 years (0.2–17). A total of 2,194 nonfasting blood samples were collected longitudinally for determination of total cholesterol, LDL cholesterol, HDL cholesterol, TG, and non-HDL cholesterol. Additional annually collected data on anthropometric parameters, A1C, and albumin-to-creatinine ratio (ACR) were available. RESULTS: Total cholesterol, LDL cholesterol, HDL cholesterol, and non-HDL cholesterol were higher in females than in males (all P < 0.001). A significant proportion of subjects presented sustained lipid abnormalities during follow-up: total cholesterol >5.2 mmol/l (18.6%), non-HDL cholesterol >3.4 mmol/l (25.9%), TG >1.7 mmol/l (20.1%), and LDL cholesterol >3.4 mmol/l (9.6%). Age and duration were significantly related to all lipid parameters (P < 0.001); A1C was independently related to all parameters (P < 0.001) except HDL cholesterol, whereas BMI SD scores were related to all parameters (P < 0.05) except total cholesterol. Total cholesterol and non-HDL cholesterol were independently related to longitudinal changes in ACR (B coefficient ± SE): 0.03 ± 0.01/1 mmol/l, P = 0.009, and 0.32 ± 0.014/1 mmol/l, P = 0.02, respectively. Overall mean total cholesterol and non-HDL cholesterol were higher in microalbuminuria positive (n = 115) than in normoalbuminuric subjects (n = 780): total cholesterol 4.7 ± 1.2 vs. 4.5 ± 0.8 mmol/l (P = 0.04) and non-HDL cholesterol 3.2 ± 1.2 vs. 2.9 ± 0.8 mmol/l (P = 0.03). CONCLUSIONS: In this longitudinal study of adolescents with type 1 diabetes, sustained lipid abnormalities were related to age, duration, BMI, and A1C. Furthermore, ACR was related to both total cholesterol and non-HDL cholesterol, indicating a potential role in the pathogenesis of diabetic nephropathy. American Diabetes Association 2009-04 2009-01-26 /pmc/articles/PMC2660471/ /pubmed/19171721 http://dx.doi.org/10.2337/dc08-1641 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Original Research Marcovecchio, M. Loredana Dalton, R. Neil Prevost, A. Toby Acerini, Carlo L. Barrett, Timothy G. Cooper, Jason D. Edge, Julie Neil, Andrew Shield, Julian Widmer, Barry Todd, John A. Dunger, David B. Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title | Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title_full | Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title_fullStr | Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title_full_unstemmed | Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title_short | Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes |
title_sort | prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660471/ https://www.ncbi.nlm.nih.gov/pubmed/19171721 http://dx.doi.org/10.2337/dc08-1641 |
work_keys_str_mv | AT marcovecchiomloredana prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT daltonrneil prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT prevostatoby prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT acerinicarlol prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT barretttimothyg prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT cooperjasond prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT edgejulie prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT neilandrew prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT shieldjulian prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT widmerbarry prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT toddjohna prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes AT dungerdavidb prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes |